A Phase 1b Viral Kinetic Study of VX-950 and Peginterferon in Hepatitis C
A Phase 1b Viral Kinetic Study of VX-950 and Peginterferon in Hepatitis C
VX-950 is an investigational drug , which is being tested in combination with a known treatment for hepatitis C, peginterferon.
Inclusion Criteria:
Exclusion Criteria: